What Should Be in the Written Consent Form for a Hair Transplant in Turkey?

Physician and patient discussing a hair transplant treatment plan

Medical review: Estexper Medical Editorial Team

A written consent form for a hair transplant in Turkey should be more than a document presented for signature immediately before treatment. It should record a genuine informed-consent process in which the patient understands the proposed procedure, its possible benefits and limitations, material risks, alternatives and the care required afterward.

In Short

A hair transplant consent form should clearly identify the patient, clinic and responsible clinicians; explain the planned technique, expected limitations, risks and alternatives; and document that consent was voluntary and understood. International patients should receive consent, treatment and discharge information in a language they understand, together with clear aftercare and follow-up arrangements.

For international patients, the document also has an important practical purpose. It should identify who is providing the treatment, clarify what has been planned, explain how communication will take place and set out what happens after the patient returns home. Turkish Ministry of Health materials for international patients emphasize that consent information and treatment or discharge information should be provided in a language the patient understands.

There is no single universally accepted hair-transplant consent template for every clinic or patient. The form should therefore be individualized, completed after a qualified physician has assessed suitability, and reviewed for compliance with Turkish law and the clinic’s regulatory obligations. The following checklist explains what patients should expect to see.

Why written consent matters

Consent is an ongoing communication process, not simply a signature. Before agreeing to a hair transplant, the patient should have an opportunity to discuss the diagnosis, the reasons for treatment, the proposed technique, likely outcomes, limitations and possible complications.

A suitable form helps document that discussion. It should show that the decision was made voluntarily, by a person with the capacity to decide, and without pressure to proceed. It should also confirm that the patient was able to ask questions and received understandable answers.

Because hair transplantation is generally an elective procedure, realistic expectations are especially important. A consent form should not promise a particular density, hairline or cosmetic result. The final appearance may be affected by donor supply, hair characteristics, future hair loss, the underlying diagnosis, healing and the growth of transplanted grafts.

Essential identification and treatment details

The first part of the document should make clear who is consenting to what treatment and who is responsible for providing it. It should normally include:

The patient’s full name and identifying details.
The date of the consultation and the proposed procedure.
The name and address of the healthcare facility.
The name, professional role and relevant responsibility of the clinician providing the information.
The identity and role of the clinician performing or supervising the intervention.
The names or roles of other healthcare professionals involved, where relevant.
The patient’s preferred language and details of an interpreter if one is required.
A space for the patient’s and relevant clinician’s signatures and the date and time of consent.

For an international patient, it is reasonable to ask whether the clinic is appropriately authorized to provide the service and whether the person giving the consultation is the same clinician who will perform or supervise the procedure. If a coordinator has been involved, the consent form should not obscure the distinction between administrative support and clinical responsibility.

Diagnosis, candidacy and the reason for treatment

The form should explain the condition being treated and why hair transplantation is being considered. This may include the pattern and cause of hair loss as assessed by the physician, rather than simply describing the patient as having “baldness.” The diagnosis and assessment should be individualized.

It should also record the physician’s assessment of candidacy. Suitability may depend on factors such as the available donor area, the condition of the scalp, the expected course of future hair loss, previous scalp procedures and the patient’s general medical history. A consultation should address whether the proposed plan is realistic for the patient’s goals.

A consent form should not be used to make a patient suitable for surgery. If the diagnosis is uncertain, the donor supply appears inadequate or expectations are not realistic, the appropriate next step may be further assessment, postponement or a decision not to proceed. Individual suitability must be determined by a qualified physician.

The proposed hair-transplant plan

The document should describe the planned intervention in specific terms. Depending on the case, this may include:

The proposed technique, such as follicular unit extraction (FUE) or follicular unit transplantation (FUT).
The donor area and recipient areas.
The estimated number of grafts or follicular units, while making clear that an estimate is not a guaranteed final number.
The intended hairline or areas of coverage, where applicable.
The method of preparing and placing grafts.
The type of local anesthesia and any planned sedation.
The expected stages or sessions of treatment.
Any circumstances that could require a change to the plan during treatment.

FUE and FUT involve different approaches and may have different considerations, including the way grafts are removed and the type of donor-area scarring that may occur. The form should explain the technique selected for that particular patient and why it has been proposed. It should not present one method as universally appropriate.

The expected goals should be described carefully. These may concern coverage or an improvement in the appearance of thinning areas, but the form should also state the limitations of treatment. Hair transplantation does not stop every possible cause of future hair loss, and transplanted grafts may not produce the exact density or appearance the patient imagines.

Medical history and factors affecting risk

Before signing, the patient should provide accurate information about their health. The consultation and consent record should address relevant factors such as:

Previous diagnoses and scalp procedures.
Allergies or previous reactions to medicines or anesthetic agents.
Current medicines and supplements.
Conditions or medicines that may affect bleeding or healing.
Smoking and other relevant lifestyle factors.
Medical conditions that may affect candidacy or recovery.
Previous problems with scarring, including keloid formation where relevant.

Patients should not stop prescribed medicines or change their routine solely because a form mentions bleeding or healing. Any changes should be discussed with the responsible physician. The purpose of recording this information is to support safe assessment and individualized counselling.

Risks and possible unwanted outcomes

Material risks should be explained in patient-understandable language. The exact risks vary according to the technique, patient factors, provider experience and other circumstances, so the consent discussion should be personalized rather than copied from a generic list.

Possible risks and unwanted outcomes associated with hair transplantation may include:

Pain, tenderness, swelling or edema.
Bleeding, bruising or infection.
Numbness or altered sensation in the donor or recipient areas.
Folliculitis, crusting or inflammation.
Temporary shedding or shock loss.
Graft loss, poor growth or an uneven result.
Scarring, including the possibility of noticeable scarring or keloid formation in susceptible individuals.
Donor-site depletion or an appearance that is less satisfactory than expected.
Skin injury or necrosis.
An unnatural hairline, direction, density or overall appearance.
Dissatisfaction with the result.
The possibility of revision or additional procedures.

The form should also explain what the patient should do if a complication is suspected, whom to contact and whether urgent assessment may be required. A list of risks is not sufficient if the patient is not told how concerns will be managed.

Alternatives, postponement and declining treatment

Informed consent requires a discussion of reasonable alternatives, including the option of no treatment. Depending on the patient’s diagnosis and goals, alternatives may include postponing the procedure for further assessment, choosing a different hair-transplant technique or deciding not to undergo transplantation.

The consequences of declining or postponing treatment should be explained without pressure. For example, the patient may continue to experience hair loss or may later have different donor or recipient-area considerations, but the form should avoid unsupported predictions. The patient should be given enough information to compare the proposed procedure with the alternatives that are relevant to their circumstances.

Consent should remain voluntary. Discounts, travel arrangements, package services or a patient’s limited time in Turkey should not replace a proper clinical discussion or pressure the patient into signing.

Language, interpretation and copies for international patients

An international patient should receive the consent information in a language they understand. If an interpreter is needed, the form should record that interpretation was provided and identify the interpreter where appropriate. Patients should not sign a document they cannot read or understand.

Turkish Ministry of Health materials for international patients also emphasize signatures by the patient and the doctor providing the information and performing the intervention, as applicable, as well as treatment findings, discharge information and post-discharge instructions in the patient’s own language. Patients should ask for a copy of the completed and signed consent form before leaving the clinic.

Translated information should be consistent with the original clinical explanation. If the patient notices a difference between a sales message, an email, a translator’s explanation and the written consent form, they should ask the responsible clinician to clarify it before proceeding.

Recovery, aftercare and follow-up responsibilities

The consent package should explain what the patient will need to do after the procedure. It should include understandable instructions about wound or scalp care, washing, physical activity, medicines if prescribed, expected symptoms and warning signs. Instructions should be individualized by the treating team rather than treated as a substitute for clinical advice.

For patients travelling home, the form or accompanying discharge document should state:

How and when follow-up will take place.
Which clinic or clinician should be contacted with questions.
How urgent concerns will be handled after departure from Turkey.
What information should be given to a local doctor if assessment is needed at home.
How the patient can obtain relevant clinical records, photographs or treatment findings.

The clinic should be clear about what follow-up it can provide remotely and what requires in-person medical assessment. A patient should not assume that a coordinator, hotel representative or travel company can provide medical care.

Keep optional permissions separate

Consent to clinical treatment should be separate from optional permissions. A patient may be asked for additional consent regarding clinical photography, educational use of images, marketing or social-media publication, sharing health information with a coordinator or insurer, or receiving promotional communications.

These permissions should be specific, voluntary and capable of being refused without affecting access to treatment. A patient may agree to photographs for medical records but decline permission for advertising. The form should make those choices clear instead of combining them into one compulsory signature.

Questions to ask before signing

Before signing a hair transplant consent form in Turkey, patients may wish to ask:

What is my diagnosis, and why am I considered suitable for this procedure?
Which technique is planned, and why is it appropriate for me?
Who will perform or supervise each part of the treatment?
How many grafts are estimated, and what are the limitations of that estimate?
What results are realistic in my case, and what may limit them?
Which risks are particularly relevant to my medical history?
What alternatives, including postponing or declining treatment, should I consider?
What written aftercare and emergency contact information will I receive?
How will follow-up and complication management work after I return home?
Can I receive a copy of the signed consent and discharge documents in a language I understand?

If the answers are unclear, the patient should request more time or seek an independent medical or legal opinion before signing. A signature should confirm understanding, not simply acknowledge receipt of a sales presentation.

Final checklist

A well-prepared consent form for hair transplantation in Turkey should identify the patient, clinician and facility; record the diagnosis and candidacy assessment; describe the technique, treatment areas, estimated grafts and anesthesia; explain expected benefits and limitations; disclose individualized risks; discuss alternatives and the consequences of declining treatment; document medical history and questions; provide aftercare and follow-up instructions; and confirm voluntary consent in an understandable language.

Because hair-transplant-specific standardized consent guidance remains limited, clinics should adapt their documents to the individual patient and obtain appropriate Turkish medical-legal or regulatory advice before using a template. Patients should expect a conversation with the responsible clinician, not a signature-only waiver.